Elotuzumab is a drug used for the treatment of multiple myeloma. It is for use in patients who have received one to three prior medications and is intended to be used in combination with lenalidomide and dexamethasone. It is given as an injection into a vein through an IV.

SparkCures ID 37
Developed By Bristol-Myers Squibb
Brand Name Empliciti®
Generic Name Elotuzumab
Additional Names HuLuc63
Treatment Classifications
Treatment Targets

Clinical Trials


There are no resources, links or videos to display for this treatment.